Furthermore, due to the role of TIAM1 in promoting a more mesenchymal phenotype, and given the role of EMT in promoting drug resistance (11), it may be of importance in therapeutic resistance of NSCLC. Here, TIAM1 is linked to non-small cell lung carcinoma.